Scoop has an Ethical Paywall
ElderCare Appoints New Director to the Board
MEDIA RELEASE
ElderCare Appoints New Director to
the Board
Auckland – March 14, 2002 – Listed
healthcare provider, ElderCare New Zealand (NZSE: ELD) today
announced that it has appointed Dr Clint Teague, managing
partner of the recently acquired Medical Laboratory
Wellington and Nelson Diagnostic Laboratories, to its board
of directors.
Said ElderCare’s CEO and director, Alan Clarke, “We are very pleased with the opportunity to have Dr Teague join the board. He brings a wealth of experience in the pathology industry to the company, and as ElderCare’s growth unfolds we will draw on this medical experience.”
The appointment follows a successful capital raising last year, and the acquisition of the Wellington and Nelson pathology businesses in January 2002.
ENDS
Company Background
ElderCare New Zealand
Limited (NZSE: ELD) is a medical and healthcare service
provider. The company owns a substantial portfolio of
nursing homes, assisted living, assessment and
rehabilitation facilities throughout New Zealand, and two
pathology businesses. These offer an array of specialised
services to cater for the healthcare needs of a broad range
of New Zealanders. The company has embarked on a programme
that will see it expand its operations into other fee income
generating businesses in the wider healthcare sector.
John Mazenier: Gaffer Tape And Glue Delivering New Zealand’s Mission Critical Services
Earthquake Commission: Ivan Skinner Award Winner Inspired By Real-life Earthquake Experience
Reserve Bank: Consultation Opens On A Digital Currency For New Zealand
NIWA: Ship Anchors May Cause Extensive And Long-lasting Damage To The Seafloor, According To New Research
New Zealand Customs Service: A Step Forward For Simpler Trade Between New Zealand And Singapore
Horizon Research: 68% Say Make Banks Offer Fraud Protection
